Pharmaceuticals

Personalized Medicine Market Forecast 2026: Where the Industry Is Headed

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the personalized medicine market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Personalized Medicine Market covering 2026–2035?

The personalized medicine market has experienced rapid expansion in recent years. It is projected to grow from $422.9 billion in 2025 to reach $469.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. This historical growth can be attributed to several factors including the rising prevalence of chronic diseases, advancements in genetic sequencing, increased healthcare expenditure, growing awareness of personalized medicine, and the early adoption of digital health solutions.

The personalized medicine market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $733.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. Key factors driving this growth during the forecast period include the incorporation of AI into diagnostics and therapeutics, the proliferation of gene and cell therapy offerings, a rising need for remote patient observation, the creation of precise nutrition methods, and the wider acceptance of companion diagnostics. Significant developments expected in the forecast timeframe encompass personalized genetic analysis, focused medication creation, healthcare models centered around patients, distant health oversight, and preventive treatments based on lifestyle.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Personalized Medicine Market?

The expanding population affected by obesity is anticipated to fuel the expansion of the personalized medicine market in the future. Obesity is defined as an unusual or excessive build-up of body fat that can detrimentally affect individuals’ well-being. Personalized medicine plays a role in tackling the distinct genetic and molecular elements that lead to obesity, consequently providing customized and potent treatments for patients. As an illustration, in December 2024, data from the Office for Health Improvement and Disparities, a UK-based government department, indicated that from 2022 to 2023, the percentage of women identified as obese in early pregnancy stood at 25.4%. This figure saw a modest rise to 26.2% between 2023 and 2024. Consequently, the increasing number of obese individuals is a key factor propelling the expansion of the personalized medicine market.

What Segments Are Identified Within The Structure Of The Personalized Medicine Market?

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Subsegments:

1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging

2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products

3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring

4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs

Which Competitive Trends Are Impacting The Structure Of The Personalized Medicine Market?

Major companies operating in the personalized medicine market are directing their efforts toward developing technological advancements such as artificial intelligence (AI)-powered platforms to enhance diagnosis accuracy, treatment personalization, and clinical trial efficiency. AI-powered platforms utilize extensive data analysis to generate actionable insights concerning disease progression, patient response, and therapeutic outcomes. For instance, in April 2023, OM1, a US-based healthcare company leveraging real-world data and AI, patented an AI-powered platform aimed at accelerating personalized medicine. The platform facilitates tailored healthcare recommendations, supports informed decision-making for healthcare providers, and expedites clinical trials by efficiently identifying suitable patient candidates. By integrating AI-driven analytics into healthcare workflows, this technology advances personalized medicine and strengthens market growth.

Which Key Players Are Driving Competition In The Personalized Medicine Market?

Major companies operating in the personalized medicine market are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Which Region Is Projected To Lead The Personalized Medicine Market During The Forecast Period?

North America was the largest region in the personalized medicine market in 2025. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Personalized Medicine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp

Browse Through More Reports Similar to the Global Personalized Medicine Market 2026, By The Business Research Company

Personalized Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Personalized Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/personalized-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795